Isolation and In-Vitro Expansion of Human Umbilical Cord–Derived Mesenchymal Stem Cells for Regenerative and Therapeutic Applications. “

Human umbilical cord blood and tissue are valuable sources of stem cells with significant potential
in
regenerative medicine and cellular therapy. Among them, mesenchymal stem cells (MSCs)
derived from the umbilical cord are widely studied due to their self-renewal capacity, multipotent
differentiation ability, and low immunogenicity. Natural bioactive compounds such as mangiferin
have gained attention for their potential to enhance stem cell viability and therapeutic properties.
The present study focuses on the isolation and in-vitro culture of human umbilical cord–derived
mesenchymal stem cells as a foundational step for further experimental evaluation involving
mangiferin and other therapeutic approaches.
Methods
Human umbilical cord samples were collected under sterile conditions and processed in the
laboratory. The Wharton’s jelly region of the umbilical cord was dissected and subjected to
enzymatic and/or explant culture techniques for the isolation of mesenchymal stem cells. The
isolated cells were cultured in appropriate growth medium supplemented with fetal bovine serum
and antibiotics, and incubated under controlled conditions. Cell morphology, adherence properties,
and proliferation were monitored using microscopic observation. Subsequent passages were
carried out to maintain and expand the MSC population for experimental studies.
Results
The isolation process yielded spindle-shaped fibroblast-like cells characteristic of mesenchymal
stem cells. The cultured cells demonstrated strong plastic adherence and proliferative capacity
during successive passages. Morphological observation confirmed the successful establishment of
a stable MSC culture from umbilical cord tissue, providing a suitable in-vitro model for further
biological and pharmacological investigations.
Conclusion
Human umbilical cord tissue serves as an effective and non-invasive source of mesenchymal stem
cells. The successful isolation and culture of these cells establish a reliable platform for downstream
applications such as drug testing, regenerative medicine studies, and evaluation of natural bioactive
compounds like mangiferin. These findings support the potential of umbilical cord–derived MSCs
as an important cellular resource for biomedical research and therapeutic development.